Diabetes, Endocrinology and Metabolism (DEM)

Diabetes, Endocrinology and Metabolism (DEM) Research Activities

FACULTY RESEARCH INTERESTS:

Robert G. Bennett, PhD

• Role of relaxin in repair of fibrosis;
• Role of insulin degrading enzyme in the pathophysiology of diabetes.

Brian Boerner, MD

• Human pancreatic beta cell proliferation and regeneration
• Improving management and outcomes of post-transplant diabetes

Cyrus V. Desouza, MBBS

• Improving outcomes in diabetes and obesity patients using treatment algorithms;
• Mechanisms of diabetes and metabolic syndrome on vascular endothelial function;
• Role of atypical antipsychotic agents in the development of diabetes.

Whitney S. Goldner, MD

• Improving outcomes after thyroid cancer including identifying possible environmental causes of and optimizing evaluation and treatment;
• Improving glucose control in the hospitalized patient;
• Consequences of morbid obesity surgery.

Frederick G. Hamel, PhD

• Role of insulin degrading enzyme in insulin resistance caused by protease inhibitors;
• Role of insulin degrading enzyme in the pathophysiology of diabetes. 

Jennifer L. Larsen, MD

• Nontraditional risk factors for vascular disease after kidney transplantation;
• Primary prevention of diabetes and its complications, particularly renal, eye, and cardiovascular disease in African Americans, Native Americans, and/or adolescents with diabetes or obesity.
• Improving outcomes after islet, pancreas and/or kidney transplant
• Effects of immunosuppressants on insulin resistance and islet function.

Lynn R. Mack, MD

• Improving outcomes in women with diabetes during and after pregnancy;
• Improving outcomes with cystic fibrosis related diabetes or bone disease;
• Prevention and treatment of bone disease associated with transplantation.

Amy S. Neumeister, MD

• Improving glucose control in the hospitalized patient

Vijay Shivaswamy, MBBS

• Effects of immunosuppressants on insulin resistance and islet function;
• Improving outcomes after islet, pancreas and/or kidney transplant.

Saraswathi Viswanathan, PhD

• The role of adipose tissue inflammation in mediating obesity-linked metabolic disorders
• Mechanisms involved in the hypolipidemic effects of fish oil
• Fish oil and cyclooxygenases-interplay in adipose tissue
• Role of nanoformulated superoxide dismutase on adipose tissue oxidative stress